Frayling TM, Beaumont RN, Jones SE, Yaghootkar H, Tuke MA, Ruth KS, Casanova F, West B, Locke J, Sharp S, Ji Y, Thompson W, Harrison J, Etheridge AS, Gallins PJ, Jima D, Wright F, Zhou Y, Innocenti F, Lindgren CM, Grarup N, Murray A, Freathy RM, Weedon MN, Tyrrell J, Wood AR
Nausea diminished over time in the semaglutide treatment group
All the experimental procedures were approved by the National Eye Institute Animal Care and Use Committee and the Ethical Committee of University of Modena and Reggio Emilia and by the Italian Ministero della Salute (150/2021-PR) and were performed as per guidelines of the Association for Research in Vision and Ophthalmology statement for the Use of Animals in Ophthalmic and Vision Research and in accordance with the ARRIVE guidelines
When Injectable GLP-1 Therapy Makes Sense Injectable medications excel for patients with predictable schedules and consistent medication access